Company Filing History:
Years Active: 2007-2009
Title: Haydn T Jones: Innovator in Anti-Viral Compounds
Introduction
Haydn T Jones is a notable inventor based in Stevange, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of anti-viral agents. With a total of 2 patents to his name, Jones is recognized for his innovative approach to combating viral infections.
Latest Patents
Jones's latest patents focus on dimeric compounds and their use as anti-viral agents. The invention relates to compounds of general formula (I), where R is an amino or guanidino group, and R is acetyl or trifluoroacetyl. The parameters n and q can be either the same or different, selected from 0, 1, or 2. Additionally, X is defined as an optionally substituted phenyl, naphthyl, or a phenyl-Y-phenyl structure, where Y can be a covalent bond, CH, CHCH, O, or SO. The invention also includes methods for the preparation of these compounds, pharmaceutical formulations containing them, and their application in the prevention or treatment of viral infections.
Career Highlights
Haydn T Jones is currently associated with Biota Scientific Management Pty Ltd, where he continues to advance his research in pharmaceutical innovations. His work has garnered attention for its potential impact on public health, particularly in the fight against viral diseases.
Collaborations
Jones has collaborated with notable colleagues in his field, including Derek Anthony Demaine and Simon J F MacDonald. These partnerships have contributed to the development of his innovative compounds and have enhanced the research output of his team.
Conclusion
Haydn T Jones stands out as a significant figure in the realm of anti-viral research, with his innovative patents paving the way for new treatments. His contributions to the field are invaluable, and his ongoing work promises to make a lasting impact on healthcare.